4.3 Article

Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasone

Related references

Note: Only part of the references are listed.
Review Critical Care Medicine

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease - GOLD executive summary

Klaus F. Rabe et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)

Article Medicine, General & Internal

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

Peter M. A. Calverley et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Immunology

In vivo effect of an immunostimulating bacterial lysate on human B lymphocytes

G. Lanzilli et al.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2006)

Article Respiratory System

Modulation of airway inflammation to prevent exacerbations of COPD

M. Soler

EUROPEAN RESPIRATORY REVIEW (2005)

Article Critical Care Medicine

Do bacteria cause exacerbations of COPD?

JV Hirschmann

CHEST (2000)